Direct Lymphatic Immunotherapy for Metastatic Renal Cell Carcinoma
1991
Our first published data in the immunotherapy of urological cancer with Interleukin- 2 (EL-2) date from 1984 when we observed for the first time tumor regression of infiltrating bladder cancer caused only by the intralesional injection of IL-2 [1].
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
9
References
1
Citations
NaN
KQI